WD-890

· Zhejiang Wenda Pharma Technology LTD.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for WD-890, covering 2025-03-07 to 2025-04-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis [Phase 2]